Alzheimer disease: open trials in Portugal

8 open trials have a site in Portugal. Registry data; only the trial team decides who can take part.

NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora · CNS Saude Lda., Torres Vedras
Registry updated 2026-11-06
NCT07213700
InRAD Observational Study
Research · Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Hospital de Santo António, Porto
Registry updated 2026-11-06
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Lisboa Ocidental E.P.E., Lisbon · Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora · CNS Saude Lda., Torres Vedras
Registry updated 2026-10-27
NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Unidade Local De Saude De Santa Maria E.P.E., Lisbon
Registry updated 2026-10-16
NCT06937229
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora · CNS Saude Lda., Torres Vedras
Registry updated 2026-10-16
NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
CCAB Centro Clinico Academico Braga Associacao, Braga · Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Santo Antonio E.P.E., Porto · Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora · CNS Saude Lda., Torres Vedras
Registry updated 2026-10-08
NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Hospital Cuf Descobertas S.A., Lisbon · CNS Saude Lda., Torres Vedras
Registry updated 2026-09-30
NCT07459660
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Hospital Cuf Descobertas S.A., Lisbon · CNS Saude Lda., Torres Vedras
Registry updated 2026-08-07

All Alzheimer disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error